Join us via Zoom, or use this streaming link. This presentation does not qualify for CME credit.
Deprescribing Psychiatric Medications through Psychodynamic Psychopharmacology
Nicholas Hocker, MD
PGY-4 Psychiatry Resident
Learning Objectives:
- Have a working definition of psychodynamic psychopharmacology, and general principles of how it is applied to patient interactions
- Appreciate situations where psychodynamic psychopharmacology may inform deprescribing of psychiatric medications.
- Differentiate treatment resistance "to" medications vs resistance "from" medications.
- Consider a personal example of patient care and how it relates to topics discussed today
Inpatient Buprenorphine Induction in the Fentanyl Era
Kimi Ge, MD
PGY-4 Psychiatry Resident
- Benefits of Medications for opioid use disorders (MOUD)
- Traditional buprenorphine induction strategy for patients with OUD in inpatient settings
- Unique property of fentanyl and the challenges it brings for using MOUD
- Optimal dosing of buprenorphine to ensure effective treatment results
THESE PRESENTATIONS ARE NOT ELIGIBLE FOR AMA PRA Category 1 Credit(s)™.
All faculty, CME Planning Committee members, and the CME office reviewer have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this activity.
Persons with a disability may request a reasonable accommodation, such as a sign language interpreter, by contacting us at 520-270-3213. Requests should be made as early as possible to allow time to arrange the accommodation.